Peer Review History
| Original SubmissionJuly 3, 2020 |
|---|
|
PONE-D-20-20582 Use of a modular ontology and a semantic annotation tool to describe the care pathway of patients with amyotrophic lateral sclerosis in a coordination network. PLOS ONE Dear Dr. CARDOSO, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Nov 01 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Robert Hoehndorf, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following in the Competing Interests section: "The authors have declared that no competing interests exist" We note that one or more of the authors are employed by a commercial company: Cogsonomy. 2.1. Please provide an amended Funding Statement declaring this commercial affiliation, as well as a statement regarding the Role of Funders in your study. If the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials, please review your statements relating to the author contributions, and ensure you have specifically and accurately indicated the role(s) that these authors had in your study. You can update author roles in the Author Contributions section of the online submission form. Please also include the following statement within your amended Funding Statement. “The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.” If your commercial affiliation did play a role in your study, please state and explain this role within your updated Funding Statement. 2.2. Please also provide an updated Competing Interests Statement declaring this commercial affiliation along with any other relevant declarations relating to employment, consultancy, patents, products in development, or marketed products, etc. Within your Competing Interests Statement, please confirm that this commercial affiliation does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests) . If this adherence statement is not accurate and there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. Please include both an updated Funding Statement and Competing Interests Statement in your cover letter. We will change the online submission form on your behalf. Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests 3. Please ensure that you refer to all your Figures in your text as, if accepted, production will need this reference to link the reader to the figures. 4. We note you have included tables to which you do not refer in the text of your manuscript. Please ensure that you refer to Tables in your text; if accepted, production will need this reference to link the reader to the Table. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: In this manuscript, titled ‘Use of a modular ontology and a semantic annotation tool to describe the care pathway of patients with amyotrophic lateral sclerosis in a coordination network’, the authors developed the tools, OntoPaRON and OnBaSAM, to describe the care pathway of patients with ALS based on real-life textual data from the Ile-de-France ALS network. Authors hope to identify the difficulties and needs of patients and their families at home, to understand the coordination actions implemented and to identify situations or types of patients confronted with multiple difficulties by analyzing of the textual data. Since, the references, figures and tables were not cited correctly, not easy to well understand the manuscript and go through the tools which represented in the references and used in this study. Even though, the model and algorithms used in this study are simple and not novel but authors applied them in a good way. Then, I’d rather recommend this manuscript to be published neither as current version nor minor-correction version. I believe that they need to re-organize the study to make a serious effort on improving the writing. In the following sections, the specific requirements for future publication of this study are explained in detail. 1) In the ‘Modularity of OntoPaRON’ section, it is mentioned that OntoPaRON has four modules and Table 2 showed four modules, while five modules were defined. Also, there is no reference or explanation about how and why these modules were chosen. 2) The concepts in each module should be listed. In addition, Fig. 2 shows the OntoPaRON inheritance diagram but there is no explanation about how the connecting arrows was drawn in this figure. 3) It is mentioned that the ontology includes 43 fully defined concepts. It is recommended that authors include the list of all fully defined concepts with their concepts as a supplementary data. 4) Authors used a linear regression model to investigate whether the identified themes specifically concerned patients with particular characteristics. First of all, the common term for assigning independent variables in regression is ‘X’ and ‘Y’ for dependent variable. So, it is better to change the terms to prevent the misunderstanding. It would be also interesting to see the feature importance based extracted from regression model to interpret about the importance of each independent variable explaining the fully defined concept. Minor points • All the references, figures and tables should be cited well in the entire manuscript. • I didn’t care much of typos, punctuations and grammar mistakes but there are several mistakes which authors should ask for English proof reading to improve the writing. Also, the authors need to systematically organize the usage of acronyms. Some of them not using anymore through the manuscript after the first occurrence, knowledge engineering (KE), and some mentioned for two times, natural language processing (NLP). • What is the parenthesis means in Table 3? • It is recommended that the numbers with more than 3 digits separate by ‘,’ not space and using ‘.’ for decimals. Reviewer #2: This paper describes the creation of an ontology and associated tool for characterisation and management of patients with ALS, using French textual data. Overall the study is interesting, and has produced several potentially interesting outcomes that consist in an ontology, surrounding analysis tools, and disease insights that could contribute to improved patient management. My overall comment is that certain aspects of the methodology and results are somewhat unclear, and should be improved before publication. I am, therefore, making the suggestion of major changes, not because the content of the paper is bad (this is not the case), but because some of the argumentation and explanation needs to be reformulated and extended, and there are significant formatting problems that inhibit understanding of the paper. -- > Our approach was unique inits creation of fully defined concepts at different levels of the modular ontology to address specific topics relating to healthcare trajectories. I am not entirely sure what this means, there are many ontologies and associated tools that approach characterisation of different facets of disease management (for a recent example, see the COVID-19 ontology http://www.aber-owl.net/ontology/COVID-19/ ). I would suggest that the unique approach here consists more in: - The application of ontology technology to French language clinical text - The creation of a new ontology-based semantic annotation / analysis tool - The use of the ontology to gain insight into the disease (this is mentioned in the latter part of the abstract) The later methods and results discuss the idea of 'fully defined concepts' in more detail, but it's unclear to me how they differ from the ontology modules, or what exactly makes them fully defined, as opposed to other concepts or modules in the ontology. -- The introduction discusses ALS deeply, and provides some other examples of disease-specific ontologies. However, little time is spent on applications of ontology to the area of text mining. I would suggest this review as a start: http://cobweb.cs.uga.edu/~kochut/teaching/8350/Papers/Ontologies/TextMining-RawText.pdf -- > A modular ontology seemed be the most appropriate model for taking all these aspects into account. It is unclear what a 'modular ontology' is in this context. Also the choice to use a modular design should be better explained. In fact, I note that this term is defined later in the paper, and the choice explained better (although the definition could perhaps be cited). Perhaps this implementation detail can be omitted entirely from the introduction, and left to the later, better explanation? -- There is a helpful guideline on minimum reporting for ontologies. I do not suggest that any of these , but the authors could add a note https://jbiomedsem.biomedcentral.com/articles/10.1186/s13326-017-0172-7 -- I think the explanation of the OnBaSAM tool, starting on page 8, should be further developed. What is unclear to me, is how these tools implement or replace functionality provided by the GATE framework itself. The GATE framework natively supports the use of ontologies as a resource for text mining, as evidenced by the documentation: https://gate.ac.uk/sale/tao/splitch14.html , as well as the pre-processing steps mentioned. The discussion could also include some mention of how generalisable the tools for text mining and analysis are. Could they be used with other domain ontologies? Are they available on the web? -- The methods of the validation should be more explicit: what exactly were the expert evaluators asked to do? It's unclear whether they only verified the machine-derived labels, or also created an annotation themselves. In the former case, recall is not an informative measure (or at least, it is misleading, as it does not describe the proportion of the actually existent concepts found). Optionally, the authors could consider measuring also inter-annotator agreement for the validation stage of their annotations. If not, they should mention potential limitations arising from treating non-perfect/human operators as a gold standard for evaluation. I can't further comment on the evaluation with more information about the methods. -- The ontology itself is interesting, using its own defined upper-level stratification of terms, with entity, abstract object, and ideal object. I don't think this is necessarily a bad thing, however many biomedical ontologies use the Basic Formal Ontology (BFO), to the extent they make upper level metaphysical distinctions at all. This can, in some cases, help with integration of concepts between different ontologies. It may be worth adding a small discussion of why the authors chose this different method. -- Citation number are missing in the document text, although they are listed in the references. I would suggest that 'pdflatex' should be run once more, to fill in the citation numbers in the document :-) In addition, the links given as citation for people living with ALS in France and America in the introduction lead to 404 errors. Several other links included as citations are also broken, which is possibly another issue caused by the above problem. -- The 'Construction of the OntoPaRON ontology' section mentions a standard format of single quotes for OntoPaRON and italic for relationships in the ontology. It would be helpful if the mention of italic font was italicised here to provide an example. Furthermore, it would aid understanding to highlight such terms in table 1 -- Some previous work that could be interesting for French language ontology is WHOFRE ( http://www.aber-owl.net/ontology/WHOFRE ). Could this work potentially be integrated? -- In table 1, the language names English and French should be capitalised. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Luke T Slater [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Use of a modular ontology and a semantic annotation tool to describe the care pathway of patients with amyotrophic lateral sclerosis in a coordination network. PONE-D-20-20582R1 Dear Dr. CARDOSO, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Robert Hoehndorf, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: (No Response) ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: (No Response) ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: (No Response) ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: (No Response) ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No |
| Formally Accepted |
|
PONE-D-20-20582R1 Use of a modular ontology and a semantic annotation tool to describe the care pathway of patients with amyotrophic lateral sclerosis in a coordination network. Dear Dr. Cardoso: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Robert Hoehndorf Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .